UroGen Pharma Ltd. Ordinary Shares (NASDAQ: URGN) last traded at $46.86, up 0.13% on the session. The quote above updates while this page is open; the figures below are drawn from UroGen Pharma Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
UroGen Pharma Ltd. Ordinary Shares trades on NASDAQ under the ticker URGN. Its market capitalisation is $2.29 billion.
Valuation measures for UroGen Pharma Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.29B |
|---|---|
| Enterprise value | $2.60B |
| Price / sales | 12.14 |
| Beta | 1.18 |
Trailing-twelve-month figures tagged in UroGen Pharma Ltd. Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $188.73M |
|---|---|
| Net income (TTM) | -$97.64M |
| EPS (TTM) | -$1.97 |
| Gross margin | 90.85% |
| Operating margin | -35.32% |
| Cash | $79.13M |
Range and volume for URGN over the past 52 weeks.
| 52-week high | $50.81 |
|---|---|
| 52-week low | $15.86 |
| Volume | 734.1K |
| Average volume | 806.9K |
| Previous close | $46.80 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.